Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q92847007 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241221010745.0 | ||
| 008 | 241221nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q92847007 | ||
| 024 | ‡a 0000-0003-0320-5776 ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q92847007 | ||
| 100 | 0 | ‡a Victor M Santana ‡c researcher (ORCID 0000-0003-0320-5776) ‡9 en | |
| 375 | ‡a 1 ‡2 iso5218 | ||
| 400 | 0 | ‡a Victor M Santana ‡c onderzoeker ‡9 nl | |
| 670 | ‡a Author's A phase 1 trial of everolimus and bevacizumab in children with recurrent solid tumors | ||
| 670 | ‡a Author's Role of implicit bias in pediatric cancer clinical trials and enrollment recommendations among pediatric oncology providers | ||
| 909 | ‡a (orcid) 0000000303205776 ‡9 1 | ||
| 919 | ‡a phase1trialofeverolimusandbevacizumabinchildrenwithrecurrentsolidtumors ‡A A phase 1 trial of everolimus and bevacizumab in children with recurrent solid tumors ‡9 1 | ||
| 919 | ‡a roleofimplicitbiasinpediatriccancerclinicaltrialsandenrollmentrecommendationsamongpediatriconcologyproviders ‡A Role of implicit bias in pediatric cancer clinical trials and enrollment recommendations among pediatric oncology providers ‡9 1 | ||
| 946 | ‡a b ‡9 1 | ||
| 996 | ‡2 ISNI|0000000114426692 | ||
| 996 | ‡2 SUDOC|219795886 | ||
| 996 | ‡2 PTBNP|112347 | ||
| 996 | ‡2 LC|no2006092812 | ||
| 996 | ‡2 ISNI|0000000069688828 | ||
| 996 | ‡2 BNE|XX935785 | ||
| 996 | ‡2 BIBSYS|68875 | ||
| 996 | ‡2 LC|n 2014048274 | ||
| 996 | ‡2 BNE|XX1013598 | ||
| 996 | ‡2 ISNI|0000000436772977 | ||
| 996 | ‡2 PTBNP|112337 | ||
| 996 | ‡2 ISNI|0000000068578803 | ||
| 996 | ‡2 BNE|XX1386718 | ||
| 996 | ‡2 PTBNP|1466799 | ||
| 996 | ‡2 RERO|A008942737 | ||
| 996 | ‡2 BNE|XX1259861 | ||
| 996 | ‡2 DNB|1095489739 | ||
| 996 | ‡2 LC|no2017139616 | ||
| 996 | ‡2 NSK|000257208 | ||
| 996 | ‡2 ISNI|0000000059670771 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
